Table 3.
T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 | T9 | T10 | |
---|---|---|---|---|---|---|---|---|---|---|
B | 1 (0/3) | 2 (0/4) | 0 (0/0)* | 0 (0/0)* | 0 (0/1)* | 0 (0/1)* | 0 (0/1)* | 0 (0/1)* | 0 (0/1)* | 0 (0/1)* |
L | 2.5 (0/4)♣ | 1 (0/3)*♣ | 1 (0/2)* | 1 (0/2)*♣ | 1 (0/2)*♣ | 1 (0/3)*♣ | 1 (0/3)* | 1 (0/3)* | 1 (0/3)* | 1 (0/3)*♣ |
LB | 1 (0/3)◊ | 1 (0/4) | 0 (0/2)* | 0 (0/2)* | 0 (0/1)* | 1 (0/2)*◊ | 0 (0/2)* | 0 (0/2) | 1 (0/3)♣ | 0 (0/2) |
Values are expressed as median and interquartile ranges (IQR). Percentage change, at various times, in HR, RR and SAP compared to T1 (15 min after xylazine administration). *Statistical differences of HR, RR and SAP compared to T1 (15 min after xylazine administration) in each group (p < 0.001). ♣Statistical differences between group B vs. groups L and LB (p < 0.001); ◊Statistical difference between group L vs. group LB (p < 0.001).